Entrada Therapeutics, Inc. 8-K

What Happened
On February 26, 2026, Entrada Therapeutics, Inc. (TRDA) announced its financial results for the quarter ended December 31, 2025 and provided other corporate updates. The company furnished a press release describing the results as Exhibit 99.1 to the Form 8-K. The filing states the information is being furnished (not “filed”) under the Securities Exchange Act and is not subject to Section 18 liability or incorporation by reference unless expressly stated.

Key Details

• Announcement date: February 26, 2026.
• Reporting period: quarter ended December 31, 2025.
• Press release furnished as Exhibit 99.1 to the Current Report on Form 8-K.
• Filing note: information is furnished, not filed, and is not incorporated by reference into other filings absent specific reference.

Why It Matters
This 8-K signals that Entrada has released its latest quarterly financial and corporate update — key information for investors tracking earnings, revenue, cash position, and program progress. Because the detailed figures and updates are in the furnished press release, investors should read Exhibit 99.1 to see the company’s reported financial metrics and any operational or clinical news. Also note the legal designation that the release is furnished (not filed), which affects how the information can be used in other SEC filings.